Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
6 weeks 9 hours ago
10 weeks 19 hours ago
11 weeks 1 day ago
11 weeks 1 day ago
32 weeks 1 day ago
36 weeks 2 days ago
38 weeks 36 min ago
38 weeks 19 hours ago
50 weeks 3 days ago
1 year 3 weeks ago